ALS TDI -The First Non Profit Biotech, A Hidden Investment Opportunity?

Strategically, the organization has done a good job in moving drugs through clinical trials but lacks venture capital funding. But the benefit investors stand to gain is a major stakehold in the drug with a low investment.

Read more »